Physician profile
Christopher H Gram
NPI 1528040219
$5,896.36
in general payments reported to CMS, 2019-2025
33 companies · $704 in 2025
The $704 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $599 · 2021: $287 · 2022: $950 · 2023: $1,285 · 2024: $1,091 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,048 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,047.63 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $774.44 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Janssen Pharmaceuticals, INC | $595.06 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $547.78 | 2023-2025 | Verquvo |
| Boston Scientific Corporation | $420.96 | 2019-2025 | Watchman Access System, Eluvia |
| Silk Road Medical, INC. | $400.73 | 2019-2020 | |
| Pfizer INC. | $389.51 | 2022-2025 | |
| Cook Medical LLC | $314.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.80 | 2021-2025 | Jardiance |
| Amgen INC. | $271.88 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $264.87 | 2022-2024 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $211.49 | 2021-2024 | Farxiga, Brilinta |
| Novo Nordisk INC | $194.48 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $152.10 | 2022-2023 | Eliquis |
| Abbott Laboratories | $118.83 | 2023 | Jeti Peripheral Catheter |
| Lexicon Pharmaceuticals, INC. | $101.83 | 2023-2024 | Inpefa |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $87.03 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bolton Medical INC | $83.08 | 2025 | Treo Abdominal Stent-Graft System |
| Allergan, INC. | $79.22 | 2019 | |
| Cardiovascular Systems INC. | $72.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.82 | 2022-2025 | |
| Endologix LLC | $68.30 | 2022 | |
| Smith+Nephew, INC. | $52.24 | 2019-2025 | Grafix Pl, Stravix Mesh, Oasis |
| Davol INC. | $49.66 | 2024 | Covera |
| Philips North America LLC | $36.43 | 2023-2024 | (Br7) Peripheral Specialty Balloon |
| Bard Peripheral Vascular, INC. | $33.57 | 2021-2024 | Covera |
| Terumo Medical Corporation | $32.81 | 2024 | Glidesheath Slender |
| Becton, Dickinson and Company | $32.78 | 2024 | Lutonix Drug Coated Balloon |
| Heartflow, INC. | $32.37 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.51 | 2022-2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $25.83 | 2024 | Arcalyst |
| Shockwave Medical, INC | $22.56 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $14.38 | 2022 | |
| Osiris Therapeutics INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.